⌘K

Login Start Free

Home/Filings/4/0001048477-24-000050

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-24-000050

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:55 PM ET

Size

313.7 KB

Accession

0001048477-24-000050

Insider Transaction Report

Form 4

Period: 2024-03-15

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Award
Common Stock
2024-03-15+4,720→ 18,814 total
Tax Payment
Common Stock
2024-03-18$83.87/sh−372$31,200→ 18,442 total
Award
Stock Option (Right to Buy Common Stock)
2024-03-15+7,050→ 7,050 total
Exercise: $83.87From: 2025-03-15Exp: 2034-03-14→ Common Stock (7,050 underlying)

Footnotes (2)

[F1]Restricted stock units granted March 15, 2024. Price not applicable.
[F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Documents

3 files

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 8:55 PM ET
Size: 313.7 KB

View on SEC.gov